Mythos’s ability to autonomously exploit flaws challenges the notion of ‘secure by default’.

By integrating long-term memory, embeddings, and re-ranking, the company aims to improve trust in agent outputs.

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...